Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors

BACKGROUND: New, more effective strategies are needed to treat highly aggressive neuroblastoma. Our laboratory has previously shown that full-length Secreted Protein Acidic and Rich in Cysteine (SPARC) and a SPARC peptide corresponding to the follistatin domain of the protein (FS-E) potently block a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chlenski, Alexandre, Guerrero, Lisa J, Peddinti, Radhika, Spitz, Jared A, Leonhardt, Payton T, Yang, Qiwei, Tian, Yufeng, Salwen, Helen R, Cohn, Susan L
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895596/
https://ncbi.nlm.nih.gov/pubmed/20525313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados